Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571.
第一作者:
J A,Leeds
第一单位:
Novartis Institutes for Biomedical Research, Infectious Disease Area, Emeryville, California, USA. jennifer.leeds@novartis.com
作者:
医学主题词
抗菌药(Anti-Bacterial Agents);结合部位(Binding Sites);抗药性, 细菌(Drug Resistance, Bacterial);小肠结肠炎, 伪膜性(Enterocolitis, Pseudomembranous);人类(Humans);微生物敏感性试验(Microbial Sensitivity Tests);肽链延伸, 翻译(Peptide Chain Elongation, Translational);肽延伸因子Tu(Peptide Elongation Factor Tu);蛋白质结构, 三级(Protein Structure, Tertiary);噻唑类(Thiazoles)
DOI
10.1128/AAC.06354-11
PMID
22644023
发布时间
2023-12-13
- 浏览25
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



